Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-03-18
DOI
10.3389/fonc.2014.00055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
- (2013) S. H. Petersdorf et al. BLOOD
- Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia
- (2013) Carol O'Hear et al. CANCER
- Novel therapies for children with acute myeloid leukaemia
- (2013) A S Moore et al. LEUKEMIA
- Epidemiology of childhood acute myeloid leukemia
- (2013) Susan E. Puumala et al. PEDIATRIC BLOOD & CANCER
- Somatic Characterization of Pediatric Acute Myeloid Leukemia Using Next-Generation Sequencing
- (2013) Heather L. Schuback et al. SEMINARS IN HEMATOLOGY
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- (2012) U. Creutzig et al. BLOOD
- Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
- (2012) H. Hasle et al. BLOOD
- Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
- (2012) J. A. Pollard et al. BLOOD
- Gemtuzumab Ozogamicin: Time to Resurrect?
- (2012) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
- (2012) A K Burnett et al. LEUKEMIA
- A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
- (2011) Prakash Satwani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia
- (2011) Todd M. Cooper et al. CANCER
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
- (2011) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic and epigenetic similarities and differences between childhood and adult AML
- (2011) Caroline Juhl-Christensen et al. PEDIATRIC BLOOD & CANCER
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors in Pediatric Acute Myeloid Leukemia
- (2010) Mohamed Radhi et al. Current Hematologic Malignancy Reports
- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study
- (2009) Christian M. Zwaan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group
- (2008) Richard Aplenc et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started